US Oncology Cancer Ctr-NC Raleigh, NC - 27609

US Oncology Cancer Ctr-NC is categorized under Hemotology Diagnostic Agents in Raleigh, NC .

US Oncology Cancer Ctr-NC was established in 0, and today employs 1 to 4, earning $2.500.000 to $4.999.999 per year. This is a Hemotology Diagnostic Agents business, which does work in the B2B market, and is classified as a Hemotology Diagnostic Agents, under code number 6223100 by the NAICS.

If you are seeking more information, feel free to contact Neeraj Agrawal at the company’s single location by writing to 3320 Wake Forest Road, Raleigh, North Carolina NC 27609 or by phoning (919) 878-7854. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.

Business Name: US Oncology Cancer Ctr-NC
Contact Person: Neeraj Agrawal
Address: 3320 Wake Forest Road, Raleigh, North Carolina 27609
Phone Number: (919) 878-7854
Website Address: usoncology.com
Annual Revenue (USD): $2.500.000 to $4.999.999
Location Type: Single Location
Employee Number: 1 to 4
Business Type: B2B (Business to Business)
Business Category: Hemotology Diagnostic Agents
SIC Code: 2835
NAICS Code: 6223100
Share This Business:

US Oncology Cancer Ctr-NC was started in 0 to provide professional Hemotology Diagnostic Agents under the SIC code 2835 and NAICS code 6223100. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $2.500.000 to $4.999.999 per annum.

Feel free to contact Neeraj Agrawal for inquiries that concern US Oncology Cancer Ctr-NC by calling the company number (919) 878-7854, as your correspondence is most welcome. Additionally, the physical location of the single location of US Oncology Cancer Ctr-NC can be found at the coordinates 35.82817,-78.61985 as well as the street address 3320 Wake Forest Road in Raleigh, North Carolina 27609.

For its online presence, you may visit US Oncology Cancer Ctr-NC’s website at usoncology.com and engage with its social media outlets through on Twitter and on Facebook.